A Quick Look at Today's Ratings for AbbVie(ABBV.US), With a Forecast Between $200 to $211
Apple Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on AbbVie, Maintains $200 Price Target
Intel's AI Chip Story 'Feels Mostly MIA,' Says Analyst -- Barrons.com
Raymond James Maintains Apple(AAPL.US) With Buy Rating, Raises Target Price to $250
A Quick Look at Today's Ratings for AbbVie(ABBV.US), With a Forecast Between $200 to $214
Stifel Maintains Microsoft(MSFT.US) With Buy Rating, Maintains Target Price $475
Morgan Stanley Adjusts AbbVie Price Target to $211 From $196
AbbVie Analyst Ratings
Raymond James Adjusts Price Target on Apple to $250 From $200, Maintains Outperform Rating
Barclays Maintains Microsoft(MSFT.US) With Buy Rating, Maintains Target Price $475
Buy Rating Affirmed for AbbVie Amidst Strong Financials and Strategic Management
Barclays Reaffirms Their Buy Rating on AbbVie (ABBV)
Piper Sandler Adjusts Price Target on AbbVie to $196 From $190
Baird Maintains Apple(AAPL.US) With Buy Rating, Raises Target Price to $240
Microsoft Earnings Are Coming. An Analyst Sees Big Upside for the Stock. -- Barrons.com
Apple Price Target Raised to $265.00/Share From $245.00 by JP Morgan
Apple Analyst Ratings
Deutsche Bank Adjusts Price Target on JPMorgan Chase & Co. to $235 From $215, Maintains Buy Rating
JPMorgan Adjusts Price Target on Apple to $265 From $245, Maintains Overweight Rating